CSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk

Dow Jones

May 12

2306 GMT - CSL's downgrade to FY26 earnings revenue and profit guidance was worse than RBC Capital Markets anticipated. CSL now projects FY26 revenue of around US$15.2 billion and an underlying net profit of US$3.1 billion when currency swings are stripped out. "Whilst RBC and consensus numbers implied another downgrade, the revised FY26 guidance downgrade of 5%/9% (mid-point) to revenue/net profit was more severe than expected, as pressures within immunoglobulin and the dynamics within albumin in China persist," analyst Craig Wong-Pan says. RBC cuts its revenue and margin assumptions for CSL's Behring and Vifor businesses. This drives a 36% reduction in its price target, to A$113.00 a share. CSL ended Monday at A$100.75. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

May 11, 2026 19:06 ET (23:06 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2634525695"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2634525695\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2634525695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 07:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634525695","market":"fut","top_or_hot":-1,"title":"CSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  2306 GMT - CSL's downgrade to FY26 earnings revenue and profit guidance was worse than RBC Capital Markets anticipated. CSL now projects FY26 revenue of around US$15.2 billion and an underlying net profit of US$3.1 billion when currency swings are stripped out. \"Whilst RBC and consensus numbers implied another downgrade, the revised FY26 guidance downgrade of 5%/9% (mid-point) to revenue/net profit was more severe than expected, as pressures within immunoglobulin and the dynamics within albumin in China persist,\" analyst Craig Wong-Pan says. RBC cuts its revenue and margin assumptions for CSL's Behring and Vifor businesses. This drives a 36% reduction in its price target, to A$113.00 a share. CSL ended Monday at A$100.75. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 19:06 ET (23:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-12 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  2306 GMT - CSL's downgrade to FY26 earnings revenue and profit guidance was worse than RBC Capital Markets anticipated. CSL now projects FY26 revenue of around US$15.2 billion and an underlying net profit of US$3.1 billion when currency swings are stripped out. \"Whilst RBC and consensus numbers implied another downgrade, the revised FY26 guidance downgrade of 5%/9% (mid-point) to revenue/net profit was more severe than expected, as pressures within immunoglobulin and the dynamics within albumin in China persist,\" analyst Craig Wong-Pan says. RBC cuts its revenue and margin assumptions for CSL's Behring and Vifor businesses. This drives a 36% reduction in its price target, to A$113.00 a share. CSL ended Monday at A$100.75. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 11, 2026 19:06 ET (23:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSL","symbol_name":"卡莱尔伙伴","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2634525695","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634525695","pubTimestamp":1778540760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2306 GMT - CSL's downgrade to FY26 earnings revenue and profit guidance was worse than RBC Capital Markets anticipated. CSL now projects FY26 revenue of around US$15.2 billion and an underlying net profit of US$3.1 billion when currency swings are stripped out. \"Whilst RBC and consensus numbers implied another downgrade, the revised FY26 guidance downgrade of 5%/9%  to revenue/net profit was more severe than expected, as pressures within immunoglobulin and the dynamics within albumin in China persist,\" analyst Craig Wong-Pan says. RBC cuts its revenue and margin assumptions for CSL's Behring and Vifor businesses. This drives a 36% reduction in its price target, to A$113.00 a share. CSL ended Monday at A$100.75. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate","earning"],"viewcount":null,"language":"en","relate_stocks":{"CSL":"卡莱尔伙伴"},"translate_title":"CSL的收入和利润指引下调幅度低于预期——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL":1.5},"content_text":"2306 GMT - CSL's downgrade to FY26 earnings revenue and profit guidance was worse than RBC Capital Markets anticipated. CSL now projects FY26 revenue of around US$15.2 billion and an underlying net profit of US$3.1 billion when currency swings are stripped out. \"Whilst RBC and consensus numbers implied another downgrade, the revised FY26 guidance downgrade of 5%/9% (mid-point) to revenue/net profit was more severe than expected, as pressures within immunoglobulin and the dynamics within albumin in China persist,\" analyst Craig Wong-Pan says. RBC cuts its revenue and margin assumptions for CSL's Behring and Vifor businesses. This drives a 36% reduction in its price target, to A$113.00 a share. CSL ended Monday at A$100.75. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 19:06 ET (23:06 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}